Accelerate market access, optimize outcomes, and unlock the value of claims, EHR, and registry data with AI-powered analytics built for payers, biopharma, and HTA bodies.
Purpose-built analytics to support market access, formulary positioning, and evidence generation
Evidence-backed insights to support optimal formulary tier placement and coverage decisions.
Demonstrate cost-effectiveness and value with rigorous real-world economic analyses.
Generate evidence for label expansion opportunities without the burden of additional RCTs.
Use real-world data to inform clinical trial design, endpoints, and patient selection.
LLM-powered natural language querying for instant insights from complex datasets.
Advanced machine learning models for treatment effectiveness estimation and prediction.
We transform claims, EHR, and registry data into actionable evidence for coverage, reimbursement, value-based care, and population health decisions.
Comprehensive RWE solutions designed to support every stage of the market access journey
Build compelling evidence packages that demonstrate clinical and economic value to support payer negotiations and formulary placement decisions.
Structured evidence submissions aligned with NICE, ICER, and global HTA requirements.
Craft data-driven narratives that communicate therapeutic value to all stakeholders.
Design and support outcomes-based agreements with real-world performance monitoring.
Evidence-driven engagement strategies for health plans and pharmacy benefit managers.
Purpose-built analytics for payers seeking to optimize formularies, manage costs, and improve population health outcomes.
Claims and EHR-based comparative studies for formulary decisions
Advanced cohort synthesis and propensity score matching
Interoperable data structuring for seamless integration
Optimize spend with cost, outcome, and rebate analytics
Specialized RWE capabilities across high-priority therapeutic areas
Glycemic control, complications, and economic burden analyses across insulin and GLP-1 therapies.
Treatment patterns, survival analyses, and value evidence across solid tumors and hematologic malignancies.
Natural history studies, patient journey mapping, and evidence for orphan drug development.
We believe every healthcare decision from coverage to care deserves to be informed by rigorous, real-world evidence. Our mission is to democratize access to decision-grade analytics and help stakeholders improve outcomes while optimizing healthcare spend.
Schedule a 20-minute discovery call to learn how Symetrique can accelerate your market access and evidence generation capabilities.
No commitment required | 20 min conversation